Agilent Technologies, Inc.

NYSE:A

Medical - Diagnostics & Research

Healthcare
$177.33 +2.44%

+$3.04 today

Market cap
$50.00B
Beta
1.26
P/E (TTM)
25.5
EPS (TTM)
$5.00
Dividend yield
0.59%
52W Low $108.35High $160.27

Volume 2.48M

Average 2.24M

A Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

Agilent Technologies, Inc.NYSE: A

Operating Margin · Q3 FY2026 · quarter ended Jul 2026

Operating margin widens to 23.6%

Operating margin was 23.6% in Q3 FY2026, up 2.9 pp from a year earlier. On a trailing-twelve-month basis it was 22.2%, up 1.0 pp year over year. Over 3 fiscal years it narrowed by 2.3 pp.

Context

  • Operating margin widened in 1 of the last 3 fiscal years.

What to watch

Whether operating margin reaches the consensus estimate from 15 analysts of 28.5% for the fiscal year ending Oct 2026, up from 21.3% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJul 2026
23.6%+1.9 pp QoQ
Last fiscal yearOct 2025
21.3%-1.6 pp YoY
LTMJul 2026
22.2%+1.0 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+2.9 pp+5.4 pp+2.5 pp
1 year-1.6 pp+7.2 pp+8.8 pp
3 years-2.3 pp+7.8 pp+10.1 pp
5 years+11.1 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2025
21.3%
Year-over-year change
-1.6pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How A compares with its peers on the latest reported figures

  • A's LTM Jul 2026 operating margin of 22.2% is the 3rd highest of the 9 companies compared; the peer median is 15.2%.
  • Its year-over-year change of +1.0 pp is the 2nd highest of 9, against a peer median of -1.1 pp.
  • Over three fiscal years its change of -2.3 pp compares with a peer median of -4.0 pp.
A Competitors Peer median
Operating Margin for A and competitors
Company Period LTM level YoY 3-year change
MTDMettler-Toledo International Inc.LTM Jun 202628.4% +0.0 pp-1.0 pp
QGENQiagen N.V.LTM Jun 202625.3% +2.4 pp+0.1 pp
AAgilent Technologies, Inc.LTM Jul 202622.2% +1.0 pp-2.3 pp
DHRDanaher CorporationLTM Sep 202620.4% -1.7 pp-7.4 pp
TMOThermo Fisher Scientific Inc.LTM Sep 202618.0% -0.5 pp-0.8 pp
RVTYRevvity, Inc.LTM Jul 202612.3% -1.9 pp-11.1 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 20269.1% +0.3 pp-6.8 pp
WATWaters CorporationLTM Jul 20268.0% -19.7 pp-1.2 pp
BRKRBruker CorporationLTM Jun 20263.6% -1.7 pp-10.2 pp
Peer median (excluding A) 15.2%-1.1 pp-4.0 pp

Competitors are the stored peer set for A. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Revenue6.32B6.85B6.83B6.51B6.95B
Cost of Revenue2.91B3.13B3.37B2.98B3.31B
Gross Profit3.41B3.72B3.47B3.54B3.64B
Gross Margin53.9%54.4%50.7%54.3%52.4%
Research & Development441M467M481M479M455M
Selling, General & Admin1.62B1.64B1.63B1.52B1.71B
Operating Expenses2.06B2.1B2.12B2.05B2.16B
Depreciation & Amortization321M317M271M257M288M
EBITDA1.76B1.91B1.7B1.87B1.84B
EBITDA Margin27.9%27.8%24.9%28.8%26.4%
Operating Income1.35B1.62B1.35B1.49B1.48B
Operating Margin21.3%23.6%19.8%22.9%21.3%
Interest Income2M9M51M80M62M
Interest Expense81M84M95M96M112M
Other Income / Expenses13M(114M)(11M)33M(44M)
Income Before Tax1.36B1.5B1.34B1.52B1.44B
Pre-Tax Margin21.5%22.0%19.6%23.4%20.7%
Income Tax Expense150M250M99M232M132M
Net Income1.21B1.25B1.24B1.29B1.3B
Net Margin19.1%18.3%18.1%19.8%18.8%
EPS (Basic)3.984.194.224.444.59
EPS (Diluted)3.944.184.194.434.57
Weighted Avg Shares304M299M294M290M283M
Weighted Avg Shares (Diluted)307M300M296M291M284M

Agilent Technologies, Inc.

NYSE:A

Intrinsic Alpha fair value

Locked

Current Price

$177.33

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.